443 related articles for article (PubMed ID: 9414189)
21. Apoptotic activity and bcl-2 immunoreactivity in meningiomas. Association with grade and outcome.
Abramovich CM; Prayson RA
Am J Clin Pathol; 2000 Jul; 114(1):84-92. PubMed ID: 10884803
[TBL] [Abstract][Full Text] [Related]
22. Scalp Invasion by Atypical or Anaplastic Meningioma Is a Risk Factor for Development of Systemic Metastasis.
Garzon-Muvdi T; Maxwell R; Luksik A; Kessler R; Weingart J; Olivi A; Bettegowda C; Tamargo R; Brem H; Lim M
World Neurosurg; 2020 Oct; 142():e133-e139. PubMed ID: 32599198
[TBL] [Abstract][Full Text] [Related]
23. Atypical and malignant meningiomas: a clinicopathological review.
Mahmood A; Caccamo DV; Tomecek FJ; Malik GM
Neurosurgery; 1993 Dec; 33(6):955-63. PubMed ID: 8134008
[TBL] [Abstract][Full Text] [Related]
24. Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection.
Sun SQ; Kim AH; Cai C; Murphy RK; DeWees T; Sylvester P; Dacey RG; Grubb RL; Rich KM; Zipfel GJ; Dowling JL; Leuthardt EC; Leonard JR; Evans J; Simpson JR; Robinson CG; Perrin RJ; Huang J; Chicoine MR
Neurosurgery; 2014 Oct; 75(4):347-54; discussion 354-5; quiz 355. PubMed ID: 24932707
[TBL] [Abstract][Full Text] [Related]
25. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.
Gousias K; Schramm J; Simon M
J Neurosurg; 2016 Sep; 125(3):551-60. PubMed ID: 26824369
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases.
Wang XQ; Jiang CC; Zhao L; Gong Y; Hu J; Chen H
J Neurosurg Pediatr; 2012 Nov; 10(5):423-33. PubMed ID: 22938082
[TBL] [Abstract][Full Text] [Related]
27. Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies.
Puripat N; Loharamtaweethong K
Virchows Arch; 2019 Jan; 474(1):87-96. PubMed ID: 30267302
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.
Perry A; Stafford SL; Scheithauer BW; Suman VJ; Lohse CM
Cancer; 1998 Jun; 82(11):2262-9. PubMed ID: 9610708
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis.
Nakasu S; Nakasu Y
Brain Tumor Pathol; 2021 Apr; 38(2):81-95. PubMed ID: 33403457
[TBL] [Abstract][Full Text] [Related]
30. Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning.
Mantle RE; Lach B; Delgado MR; Baeesa S; Bélanger G
J Neurosurg; 1999 Sep; 91(3):375-83. PubMed ID: 10470810
[TBL] [Abstract][Full Text] [Related]
31. Results of attempted radical tumor removal and venous repair in 100 consecutive meningiomas involving the major dural sinuses.
Sindou MP; Alvernia JE
J Neurosurg; 2006 Oct; 105(4):514-25. PubMed ID: 17044551
[TBL] [Abstract][Full Text] [Related]
32. Anterior visual pathway meningiomas primarily resected between 1978 and 1988: the Mayo Clinic Rochester experience.
Stafford SL; Perry A; Leavitt JA; Garrity JA; Suman VJ; Scheithauer BW; Lohse CM; Meyer FB
J Neuroophthalmol; 1998 Sep; 18(3):206-10. PubMed ID: 9736208
[TBL] [Abstract][Full Text] [Related]
33. The role of radiotherapy following gross-total resection of atypical meningiomas.
Komotar RJ; Iorgulescu JB; Raper DM; Holland EC; Beal K; Bilsky MH; Brennan CW; Tabar V; Sherman JH; Yamada Y; Gutin PH
J Neurosurg; 2012 Oct; 117(4):679-86. PubMed ID: 22920955
[TBL] [Abstract][Full Text] [Related]
34. Standardisation of canine meningioma grading: Inter-observer agreement and recommendations for reproducible histopathologic criteria.
Belluco S; Marano G; Baiker K; Beineke A; Oevermann A; Seehusen F; Boracchi P; Pumarola M; Mandara MT
Vet Comp Oncol; 2022 Jun; 20(2):509-520. PubMed ID: 35066998
[TBL] [Abstract][Full Text] [Related]
35. Predicting recurrence of intracranial meningiomas. A multivariate clinicopathologic model--interim report of the New York University Medical Center Meningioma Project.
Miller DC
Neurosurg Clin N Am; 1994 Apr; 5(2):193-200. PubMed ID: 8032222
[TBL] [Abstract][Full Text] [Related]
36. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
37. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.
Pasquier D; Bijmolt S; Veninga T; Rezvoy N; Villa S; Krengli M; Weber DC; Baumert BG; Canyilmaz E; Yalman D; Szutowicz E; Tzuk-Shina T; Mirimanoff RO;
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1388-93. PubMed ID: 18294779
[TBL] [Abstract][Full Text] [Related]
38. A Risk Score Based on 5 Clinico-Pathological Variables Predicts Recurrence of Atypical Meningiomas.
Fioravanzo A; Caffo M; Di Bonaventura R; Gardiman MP; Ghimenton C; Ius T; Maffeis V; Martini M; Nicolato A; Pallini R; Pegolo E; Pinna G; Sala F; Skrap M; Volpin V; Barresi V
J Neuropathol Exp Neurol; 2020 May; 79(5):500-507. PubMed ID: 32232472
[TBL] [Abstract][Full Text] [Related]
39. Surgery for convexity meningioma: Simpson Grade I resection as the goal: clinical article.
Hasseleid BF; Meling TR; Rønning P; Scheie D; Helseth E
J Neurosurg; 2012 Dec; 117(6):999-1006. PubMed ID: 23061394
[TBL] [Abstract][Full Text] [Related]
40. Benign versus atypical meningiomas: risk factors predicting recurrence.
Nowak A; Dziedzic T; Krych P; Czernicki T; Kunert P; Marchel A
Neurol Neurochir Pol; 2015; 49(1):1-10. PubMed ID: 25666766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
